Oragenics, Inc. – Securities Purchase Agreement (August 13th, 2007)
This Securities Purchase Agreement (this Agreement) is dated as of July 18, 2007, by and among Oragenics, Inc, a Florida corporation (the Company) and the individuals or entities set forth on the signature page to this Agreement (each a Purchaser and collectively the Purchasers).
Oragenics, Inc. – Registration Rights Agreement (August 13th, 2007)
This Registration Rights Agreement (this Agreement) is made and entered into as of August 7, 2007, by and among Oragenics, Inc, a Florida corporation (the Company), and the investors signatory hereto (each a Purchaser and collectively, the Purchasers).
Oragenics, Inc. – Stock Purchase Agreement (December 5th, 2006)
THIS STOCK PURCHASE AGREEMENT dated as of September 27, 2006 (the Effective Date) is by and among ORAGENICS, INC., a Florida corporation (the Purchaser), IVIGENE CORPORATION, a Delaware corporation (the Company), and the individuals and entities whose names are set forth on the signature pages hereto being all of the holders of all of the issued and outstanding shares of the capital stock of the Company (each a Stockholder and collectively, the Stockholders).
Oragenics, Inc. – Contract (March 10th, 2006)
Exhibit 4.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of January 6, 2006, by and among Oragenics, Inc, a Florida corporation (the "Company) and George Hawes and his assignees (each a "Purchaser" and collectively the "Purchasers"). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to applicable exemptions from registration under the Securities Act of 1933, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company shares of Common Stock and Warrants to purchase shares of Common Stock as set forth herein. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the parties agree as follows: DEFINITIONS
Oragenics, Inc. – Contract (March 10th, 2006)
Exhibit 4.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of January 6, 2006, by and among Oragenics, Inc, a Florida corporation (the "Company"), and the persons signatory hereto (each a "Purchaser" and collectively, the "Purchasers"). This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof among the Company and the Purchasers (the "Purchase Agreement"). The Company and the Purchasers hereby agree as follows: Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings: "Effectiveness Period" shall have the meaning set forth in Section 2. "Filing Date" means, with respect to the Registration Statement re
Oragenics, Inc. – Contract (March 8th, 2006)
Exhibit 10.46 February 3, 2006 Dr. Ann Progulske-Fox 6392 County Road 214 Keystone Heights, FL 32656 Dear Ann: I am writing to you in regard to the license arrangement between iviGene Corporation and Oragenics, Inc. as detailed in the Memorandum of Agreement dated February 9, 2004 (a copy of which is attached). Oragenics has agreed to pursue development of the licensed technologies and as such paragraph 4 on page two requires that we maintain "A commitment of two full-time staff people equivalent or an annual expenditure of $150,000 in 2004 and $200,000 in each year thereafter..." Although we effectively met this commitment in 2004, in 2005 we worked approximately 3,400 hours and spent approximately $166,000 on the IVIAT and CMAT technologies. As you know, Oragenics has worked diligently to advance these technologies and we would like to continue the operation of our license agreement. To that end, we request a waiver from iviGene Corporation with regard to the staff hours and ex
Oragenics, Inc. – Contract (August 11th, 2005)
Exhibit 10.2 June 30, 2005 Dr. Robert T. Zahradnik 119 Ashlei Lane Searcy, AK 72143 We are pleased to offer you, Robert T. Zahradnik (the "employee"), employment with Oragenics, Inc. (the "employer") whereby you will work with executive management performing various tasks as requested by our Board of Directors. You will be reporting directly to David Gury, Chairman of the Board of Directors. Compensation Your start date will be July 1, 2005 and you will be paid a monthly base salary of $15,000. This employment arrangement will be "at will" and may terminate upon 30 days written notice by either the employer or employee. Benefits Insurance You are eligible for medical, dental, life insurance benefits on August 1, 2005. Our current plan is provided by Blue Cross/Blue Shield. We will pay 90% of the premium for you. A copy of the plan will be provided directly from Blue Cross/Blue Shield. Retirement Plan You are also eligible for the company's Simple Retirement Plan immediately